DNA Binding and Molecular Dynamic Studies of Polycyclic Tetramate Macrolactams (PTM) with Potential Anticancer Activity Isolated from a Sponge-Associated Streptomyces zhaozhouensis subsp. mycale subsp. nov

Mar Biotechnol (NY). 2019 Feb;21(1):124-137. doi: 10.1007/s10126-018-9866-9. Epub 2018 Dec 13.

Abstract

A sponge-associated actinomycete (strain MCCB267) was isolated from a marine sponge Mycale sp. collected in the Indian Ocean off the Southeast coast of India. Phylogenetic studies of this strain using 16S rRNA gene sequencing showed high sequence similarity to Streptomyces zhaozhouensis. However, strain MCCB267 showed distinct physiological and biochemical characteristic features and was thus designated as S. zhaozhouensis subsp. mycale. subsp. nov. A cytotoxicity-guided fractionation of the crude ethyl acetate extract of strain MCCB267 culture medium yielded four pure compounds belonging to the polycyclic tetramate macrolactam (PTM) family of natural products: ikarugamycin (IK) (1), clifednamide A (CF) (2), 30-oxo-28-N-methylikarugamycin (OI) (3), and 28-N-methylikarugamycin (MI) (4). The four compounds exhibited promising cytotoxic activity against NCI-H460 lung carcinoma cells in vitro, by inducing cell death via apoptosis. Flow cytometric analysis revealed that 1, 3, and 4 induced cell cycle arrest during G1 phase in the NCI-H460 cell line, whereas 2 induced cell arrest in the S phase. A concentration-dependent accumulation of cells in the sub-G1 phase was also detected upon treatment of the cancer cell line with compounds 1-4. The in vitro cytotoxicity studies were supported by molecular docking and molecular dynamic simulation analyses. An in silico study revealed that the PTMs can bind to the minor groove of DNA and subsequently induce the apoptotic stimuli leading to cell death. The characterization of the isolated actinomycete, the study of the mode of action of the four PTMs, 1-4, and the molecular docking and molecular dynamic simulations analyses are herein described.

Keywords: Anticancer; Apoptosis; Clifednamide; Ikarugamycin; Polycyclic tetramate macrolactams; Streptomyces.

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / isolation & purification
  • Antineoplastic Agents / pharmacology
  • Apoptosis / drug effects*
  • Apoptosis / genetics
  • Binding Sites
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • DNA / chemistry*
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism
  • Epithelial Cells / pathology
  • G1 Phase Cell Cycle Checkpoints / drug effects
  • G1 Phase Cell Cycle Checkpoints / genetics
  • Humans
  • Inhibitory Concentration 50
  • Lactams / chemistry*
  • Lactams / isolation & purification
  • Lactams / pharmacology
  • Lactams, Macrocyclic / chemistry*
  • Lactams, Macrocyclic / isolation & purification
  • Lactams, Macrocyclic / pharmacology
  • Molecular Docking Simulation
  • Nucleic Acid Conformation
  • Phylogeny
  • Porifera / microbiology
  • Porifera / physiology
  • RNA, Ribosomal, 16S / genetics
  • S Phase Cell Cycle Checkpoints / drug effects
  • S Phase Cell Cycle Checkpoints / genetics
  • Streptomyces / chemistry*
  • Streptomyces / classification
  • Streptomyces / metabolism
  • Symbiosis / physiology

Substances

  • Antineoplastic Agents
  • Lactams
  • Lactams, Macrocyclic
  • RNA, Ribosomal, 16S
  • ikarugamycin
  • DNA